Quick Answer
ClearPoint Neuro, Inc. reported Research And Development Expense of $13.90 million for the year ending 2025.
- ClearPoint Neuro, Inc. showed an increase of +12.1% in Research And Development Expense from 2024 to 2025.
- This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: $486.0 thousand | Q3 2012: $573.6 thousand | Q1 2013: $771.5 thousand | Q2 2013: $741.8 thousand | Q3 2013: $725.3 thousand | Q1 2014: $817.6 thousand | Q2 2014: $898.4 thousand | Q3 2014: $873.4 thousand | Q1 2015: $527.5 thousand | Q2 2015: $426.9 thousand | Q3 2015: $480.3 thousand | Q1 2016: $657.2 thousand | Q2 2016: $749.9 thousand | Q3 2016: $691.3 thousand | Q1 2017: $557.7 thousand | Q2 2017: $1.08 million | Q3 2017: $589.7 thousand | Q1 2018: $546.3 thousand | Q2 2018: $665.3 thousand | Q3 2018: $617.2 thousand | Q1 2019: $584.5 thousand | Q2 2019: $697.8 thousand | Q3 2019: $761.9 thousand | Q1 2020: $818.0 thousand | Q2 2020: $812.0 thousand | Q3 2020: $1.14 million | Q1 2021: $1.56 million | Q2 2021: $2.11 million | Q3 2021: $2.60 million | Q1 2022: $2.90 million | Q2 2022: $2.41 million | Q3 2022: $2.65 million | Q1 2023: $3.02 million | Q2 2023: $3.61 million | Q3 2023: $2.43 million | Q1 2024: $2.63 million | Q2 2024: $3.12 million | Q3 2024: $3.32 million | Q1 2025: $3.38 million | Q2 2025: $3.83 million | Q3 2025: $3.45 million.
- Over the full 16 years of available data (2010 to 2025), ClearPoint Neuro, Inc.'s Research And Development Expense has grown by 144.6%.
- Historical annual values: Fiscal year 2025: $13.90 million | Fiscal year 2024: $12.39 million | Fiscal year 2023: $11.71 million | Fiscal year 2022: $10.89 million | Fiscal year 2021: $9.28 million | Fiscal year 2020: $4.69 million | Fiscal year 2019: $2.81 million | Fiscal year 2018: $2.31 million | Fiscal year 2017: $2.81 million | Fiscal year 2016: $2.63 million | Fiscal year 2015: $1.96 million | Fiscal year 2014: $3.30 million | Fiscal year 2013: $2.92 million | Fiscal year 2012: $2.48 million | Fiscal year 2011: $4.25 million | Fiscal year 2010: $5.68 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: